In the past few weeks, it seems like the party for Big Tech has ended. Amid fears of a looming recession, a slew of Silicon Valley giants have announced plans to freeze hiring or lay off staff in the ...
Oppenheimer believes Integral Ad Science (IAS) could be a significant beneficiary from Meta‘s (META) announcement that it will be ending third-party fact-checking in the U.S., lifting topic ...
Eli Lilly’s Ebglyss (lebrikizumab-lbkz) has reduced the severity of atopic dermatitis (AD) in children as young as six months, with the drugmaker now eyeing an expansion to its already approved ...